Medtronic Reports First Quarter Fiscal 2027 Results; Delivers Broad-Based Portfolio Performance and Raises Fiscal 2027 Guidance

Medtronic boosts fiscal 2027 forecasts on heart device demand

Medtronic in Charts: Double-digit growth broadens across key segments in FQ1 (NYSE:MDT)

More on Medtronic plc Medtronic: The CAS Catalyst Can Close A 27% Peer Discount Medtronic: Riding On Next-Gen Tech Medical Devices Medtronic: Expecting...

Medtronic (NYSE:MDT) Announces Earnings Results

Medtronic (NYSE:MDT - Get Free Report) released its quarterly earnings results on Tuesday. The medical technology company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.06. Medtronic had a net margin of 13.20% and a return on equity of 14.51%. The company had revenue of $9.76 billion for the quarter, compared to the consensus estimate of $9.55 billion.

Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance

Strength across the company's largest franchises, new growth platforms, and recent portfolio investments support the long-term growth trajectory